Stuart Essig Appointed as Integra’s Next President and Chief Executive OfficerMichael McBreen Appointed Chief Commercial OfficerPRINCETON, N.J., ...
StockStory.org on MSN
Why are Integra LifeSciences (IART) shares soaring today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 5.3% in the afternoon session after ...
Medical device company Integra LifeSciences (NASDAQ:IART) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up ...
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting earnings this Tuesday before the bell. Here’s what to expect.
Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. Integra on Tuesday said it has signed a separation ...
Integra LifeSciences (Nasdaq:IART) announced today that it named Stuart M. Essig as its president and CEO, effective May 1. Essig, the company’s board chair, succeeds Mojdeh Poul in the corner office ...
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026. First Quarter 2026 ...
Zacks Investment Research on MSN
Integra LifeSciences (IART) expected to beat earnings estimates: What to know ahead of Q1 release
Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Integra LifeSciences (IART) reports ...
CMO Ray Turner discusses PriMatrix's non-cross-linked fetal bovine dermal matrix design, superior vascularization, and ...
Integra LifeSciences has agreed to acquire Derma Sciences for approximately $204 million, the companies said today, in a deal that the buyer said would expand its wound care offerings and regenerative ...
When Integra LifeSciences Holding Corporation (NASDAQ: IART) decided to do a 2-for-1 stock split on Jan. 4, 2017, the surgical products company no doubt thought the move would lead to a higher ...
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has signed a definitive agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results